1. Signaling Pathways
  2. Epigenetics
  3. Epigenetic Reader Domain
  4. Epigenetic Reader Domain Antagonist

Epigenetic Reader Domain Antagonist

Epigenetic Reader Domain Antagonists (2):

Cat. No. Product Name Effect Purity
  • HY-159989
    UNC10142
    Antagonist 99.74%
    UNC10142 (Compound 44) is a first-in-class small molecule antagonist of CHD1 that binds with an IC50 value of 1.7 μM. UNC10142 leads to a dose-dependent reduction in viability in PTEN-deficient prostate cancer cells.
  • HY-120772
    UNC-1679
    Antagonist
    UNC-1679 is a L3MBTL3 antagonist (Kd: 0.47 μM for L3MBTL3, 68 μM for L3MBTL1).